Silexion Therapeutics Corp
Biotechnology company · Ramat Gan, Tel Aviv, Israel · Nasdaq: SLXN
Silexion Therapeutics Corp is a biotechnology company headquartered in Ramat Gan, Tel Aviv, Israel. Its earliest recorded incorporation is in 2024. Its shares trade on Nasdaq under the ticker SLXN. It has reported private securities offerings to the US SEC, most recently $3.6 million sold in a notice filed in 2025.
Silexion Therapeutics at a glance
What does Silexion Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $3.6 million sold (2025).
Frequently asked questions about Silexion Therapeutics
Where is Silexion Therapeutics headquartered?
Silexion Therapeutics Corp is headquartered in Ramat Gan, Tel Aviv, Israel.
What does Silexion Therapeutics do?
Silexion Therapeutics Corp is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Silexion Therapeutics a public company?
Yes. Silexion Therapeutics Corp trades on Nasdaq under the ticker SLXN.
When was Silexion Therapeutics founded?
The earliest incorporation on record for Silexion Therapeutics Corp is in 2024, according to public company registers.
Similar companies
- Entera Bio Ltd.Jerusalem, Israel
- Compugen LtdH̱olon, Tel Aviv, Israel
- Pluri Inc.Haifa, Israel
- Scinai Immunotherapeutics Ltd.Jerusalem, Israel
- Gamida Cell Ltd.Jerusalem, Israel
- Atox Bio Inc.Ness Ziona, Central District, Israel
- Check-Cap Ltd‘Isfiyā, Haifa, Israel
- Pocared Diagnostics, Ltd.Reẖovot, Central District, Israel
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences